180 related articles for article (PubMed ID: 17635670)
21. Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier.
He L; Zhao C; Yan M; Zhang LY; Xia YZ
Phytother Res; 2009 Jul; 23(7):933-7. PubMed ID: 19172664
[TBL] [Abstract][Full Text] [Related]
22. Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier.
Choo EF; Kurnik D; Muszkat M; Ohkubo T; Shay SD; Higginbotham JN; Glaeser H; Kim RB; Wood AJ; Wilkinson GR
J Pharmacol Exp Ther; 2006 Jun; 317(3):1012-8. PubMed ID: 16537797
[TBL] [Abstract][Full Text] [Related]
23. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.
Schinkel AH; Wagenaar E; van Deemter L; Mol CA; Borst P
J Clin Invest; 1995 Oct; 96(4):1698-705. PubMed ID: 7560060
[TBL] [Abstract][Full Text] [Related]
24. Determinants of drug brain uptake in a rat model of seizure-associated malformations of cortical development.
Marchi N; Guiso G; Caccia S; Rizzi M; Gagliardi B; Noé F; Ravizza T; Bassanini S; Chimenti S; Battaglia G; Vezzani A
Neurobiol Dis; 2006 Dec; 24(3):429-42. PubMed ID: 17027274
[TBL] [Abstract][Full Text] [Related]
25. P-glycoprotein has negligible effects on estradiol and testosterone in mice.
Ebinger M; Behl C; Rosenhagen M; Uhr M
Neurosci Lett; 2007 Oct; 427(1):6-9. PubMed ID: 17923326
[TBL] [Abstract][Full Text] [Related]
26. Interactions between riluzole and ABCG2/BCRP transporter.
Milane A; Vautier S; Chacun H; Meininger V; Bensimon G; Farinotti R; Fernandez C
Neurosci Lett; 2009 Mar; 452(1):12-6. PubMed ID: 19146924
[TBL] [Abstract][Full Text] [Related]
27. In vitro-to-in vivo prediction of P-glycoprotein-based drug interactions at the human and rodent blood-brain barrier.
Hsiao P; Bui T; Ho RJ; Unadkat JD
Drug Metab Dispos; 2008 Mar; 36(3):481-4. PubMed ID: 18057117
[TBL] [Abstract][Full Text] [Related]
28. Brain permeability of inhaled corticosteroids.
Arya V; Issar M; Wang Y; Talton JD; Hochhaus G
J Pharm Pharmacol; 2005 Sep; 57(9):1159-67. PubMed ID: 16105236
[TBL] [Abstract][Full Text] [Related]
29. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system.
Feng B; Mills JB; Davidson RE; Mireles RJ; Janiszewski JS; Troutman MD; de Morais SM
Drug Metab Dispos; 2008 Feb; 36(2):268-75. PubMed ID: 17962372
[TBL] [Abstract][Full Text] [Related]
30. Influx and efflux transport of H1-antagonist epinastine across the blood-brain barrier.
Ishiguro N; Nozawa T; Tsujihata A; Saito A; Kishimoto W; Yokoyama K; Yotsumoto T; Sakai K; Igarashi T; Tamai I
Drug Metab Dispos; 2004 May; 32(5):519-24. PubMed ID: 15100174
[TBL] [Abstract][Full Text] [Related]
31. Disposition of everolimus in mdr1a-/1b- mice and after a pre-treatment of lapatinib in Swiss mice.
Chu C; Abbara C; Noël-Hudson MS; Thomas-Bourgneuf L; Gonin P; Farinotti R; Bonhomme-Faivre L
Biochem Pharmacol; 2009 May; 77(10):1629-34. PubMed ID: 19426700
[TBL] [Abstract][Full Text] [Related]
32. Verapamil and riluzole cocktail liposomes overcome pharmacoresistance by inhibiting P-glycoprotein in brain endothelial and astrocyte cells: A potent approach to treat amyotrophic lateral sclerosis.
Yang T; Ferrill L; Gallant L; McGillicuddy S; Fernandes T; Schields N; Bai S
Eur J Pharm Sci; 2018 Jul; 120():30-39. PubMed ID: 29704642
[TBL] [Abstract][Full Text] [Related]
33. P-glycoprotein ATPase activating effect of opioid analgesics and their P-glycoprotein-dependent antinociception in mice.
Hamabe W; Maeda T; Fukazawa Y; Kumamoto K; Shang LQ; Yamamoto A; Yamamoto C; Tokuyama S; Kishioka S
Pharmacol Biochem Behav; 2006 Nov; 85(3):629-36. PubMed ID: 17134744
[TBL] [Abstract][Full Text] [Related]
34. Uptake characteristics of pinocembrin and its effect on p-glycoprotein at the blood-brain barrier in in vitro cell experiments.
Yang ZH; Sun X; Qi Y; Mei C; Sun XB; Du GH
J Asian Nat Prod Res; 2012; 14(1):14-21. PubMed ID: 22263589
[TBL] [Abstract][Full Text] [Related]
35. Insulin regulates P-glycoprotein in rat brain microvessel endothelial cells via an insulin receptor-mediated PKC/NF-kappaB pathway but not a PI3K/Akt pathway.
Liu H; Yang H; Wang D; Liu Y; Liu X; Li Y; Xie L; Wang G
Eur J Pharmacol; 2009 Jan; 602(2-3):277-82. PubMed ID: 19049803
[TBL] [Abstract][Full Text] [Related]
36. Methylated beta-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood-brain barrier.
Tilloy S; Monnaert V; Fenart L; Bricout H; Cecchelli R; Monflier E
Bioorg Med Chem Lett; 2006 Apr; 16(8):2154-7. PubMed ID: 16464592
[TBL] [Abstract][Full Text] [Related]
37. Modulation of p-glycoprotein function by caveolin-1 phosphorylation.
Barakat S; Demeule M; Pilorget A; Régina A; Gingras D; Baggetto LG; Béliveau R
J Neurochem; 2007 Apr; 101(1):1-8. PubMed ID: 17326770
[TBL] [Abstract][Full Text] [Related]
38. Transport of amentoflavone across the blood-brain barrier in vitro.
Gutmann H; Bruggisser R; Schaffner W; Bogman K; Botomino A; Drewe J
Planta Med; 2002 Sep; 68(9):804-7. PubMed ID: 12357391
[TBL] [Abstract][Full Text] [Related]
39. The role of p-glycoprotein in limiting brain penetration of the peripherally acting anticholinergic overactive bladder drug trospium chloride.
Geyer J; Gavrilova O; Petzinger E
Drug Metab Dispos; 2009 Jul; 37(7):1371-4. PubMed ID: 19389858
[TBL] [Abstract][Full Text] [Related]
40. Pharmacoproteomics-based reconstruction of in vivo P-glycoprotein function at blood-brain barrier and brain distribution of substrate verapamil in pentylenetetrazole-kindled epilepsy, spontaneous epilepsy, and phenytoin treatment models.
Uchida Y; Ohtsuki S; Terasaki T
Drug Metab Dispos; 2014 Oct; 42(10):1719-26. PubMed ID: 25061162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
